The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
In recent years a growing debate is about whether botulinum neurotoxins are retrogradely transported from the site of injection. Immunodetection of cleaved SNAP-25 (cl-SNAP-25), the protein of the SNARE complex targeted by botulinum neurotoxin serotype A (BoNT/A), could represent an excellent approa...
Main Authors: | Sara Marinelli, Valentina Vacca, Ruggero Ricordy, Carolina Uggenti, Ada Maria Tata, Siro Luvisetto, Flaminia Pavone |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23110146/?tool=EBI |
Similar Items
-
Botulinum Neurotoxin for Pain Management: Insights from Animal Models
by: Siro Luvisetto, et al.
Published: (2010-12-01) -
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice
by: Valentina Vacca, et al.
Published: (2020-07-01) -
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model
by: Alba Finocchiaro, et al.
Published: (2018-03-01) -
Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications
by: Siro Luvisetto
Published: (2020-09-01) -
Botulinum Neurotoxin for the Treatment of Neuropathic Pain
by: Gabriella Egeo, et al.
Published: (2020-08-01)